Cargando…
Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia
BACKGROUND: GDF15 (growth differentiation factor 15) and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) may offer promise as biomarkers for cognitive outcomes, including dementia. We determined the association of these biomarkers with cognitive outcomes in a community‐based cohort. METHODS AN...
Autores principales: | McGrath, Emer R., Himali, Jayandra J., Levy, Daniel, Conner, Sarah C., DeCarli, Charles, Pase, Matthew P., Ninomiya, Toshiharu, Ohara, Tomoyuki, Courchesne, Paul, Satizabal, Claudia L., Vasan, Ramachandran S., Beiser, Alexa S., Seshadri, Sudha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792414/ https://www.ncbi.nlm.nih.gov/pubmed/32921207 http://dx.doi.org/10.1161/JAHA.119.014659 |
Ejemplares similares
-
Circulating IGFBP‐2: a novel biomarker for incident dementia
por: McGrath, Emer R., et al.
Publicado: (2019) -
Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019) -
Circulating ceramide ratios and risk of vascular brain aging and dementia
por: McGrath, Emer R., et al.
Publicado: (2020) -
Secular Trends in Head Size and Cerebral Volumes In the Framingham Heart Study for Birth Years 1902–1985
por: DeCarli, Charles, et al.
Publicado: (2023) -
Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
por: Lin, Honghuang, et al.
Publicado: (2022)